Expect next year to be a challenging one for health care organizations. It will be notable for its persistent uncertainty and risk for the U.S. health industry, PwC Health Research Institute's (HRI) annual report, "Top health industry issues of 2018," now in its 12th year of publication, predicts.
The discovery of several new key molecules that are involved in severe Plasmodium falciparum malaria is expected to contribute to the development of effective new vaccines and therapeutic drugs against malaria.